CAMLINFINE Camlin Fine Q2 FY26 results (Jul–Sep 2025) and concall
Camlin Fine Sciences delivered a strong Q2 FY26, with revenue growing 8.6% sequentially to ₹460 crores, driven by volume increases in both straights and blends. EBITDA saw a substantial recovery to ₹33 crores, achieving a 7.27% margin, supported by optimal plant utilization. While Vanillin volumes rose, realizations faced pressure from tariffs and channel destocking, which is projected to clear by Q4 FY26 in the US and Q1 FY27 in Europe. The company remains on track for its full-year revenue guidance and anticipates further growth from its Blends segment and the upcoming Vinpai acquisition.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 10.3%, net profit up 87.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 417 | 431 | 432 | 408 | 460 +10% |
| EBITDA | 52 | 56 | 62 | 20 | 33 −37% |
| Net profit | -116 | -7 | 0 | -11 | -15 +87% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
